Environ
High Altitude Sickness
search
High Altitude Sickness
, Acute Mountain Sickness, High Altitude Illness
See Also
High Altitude Related-Conditions
High Altitude Cerebral Edema
(
HACE
)
High Altitude Pulmonary Edema
(
HAPE
)
Portable Hyperbaric Chamber
(
Gamow Bag
)
Lake Louise Acute Mountain Sickness Score
Background
Altitudes
See
FIO2 and PiO2 at Altitude
Low Altitude: <1500 meters (<4900 feet)
High Altitude: 1500 to 3500 meters (4900 to 11500 feet)
Most common elevations for Acute Mountain Sickness: 2500 to 3500 meters (8200 to 11482 feet)
Affects the greatest number of people exposed who ascend quickly (e.g. travel to alpine city)
Colorado Ski Resorts: Affects 25% of travelers
Himalayas: Affects 50% of travelers
Very High Altitude: 3500 to 5500 meters (11500 to 18000 feet)
Blood
Oxygen Saturation
<90% even in health persons
Associated with severe Acute Mountain Sickness (as well as
HACE
and
HAPE
)
Affects 25% who climb to this altitude
Extreme Altitude: >5500 meters (>18000 feet)
Significant
Hypoxia
and hypercarbia
Affects 50% who climb above 6000 meters
Pathophysiology
Mechanism
See
FIO2 and PiO2 at Altitude
Oxygen
Partial Pressure
decreases with altitude related drop in total
Ambien
t air pressure (atmospheric pressure)
Oxygen maintains its percentage (21%) of overall gas constituents in atmospheric pressure (78% Nitrogen, 1% Argon)
However, Oxygen
Partial Pressure
drops in relation to total atmospheric pressure decrease
DRY Sea level
Partial Pressure
: 160 mmHg (21% of total atmospheric pressure, 760 mmHg)
DRY
Partial Pressure
at 5000 feet: 132 mmHg (21% of total atmospheric pressure, 630 mmHg)
Partial Pressure
is lowered by the humidified, heated air we inspire through our upper airways
Saturated vapor pressure at
Body Temperature
(98.6 F or 37 C) is 47 mmHg
Alveolar
Partial Pressure
of oxygen at sea level = 0.21 * (760 - 47 mmHg) = 0.21 * 713 = 150 mmHg
Decreased oxygen
Partial Pressure
results in fewer oxygen molecules available on inspiration of a given
Lung Volume
Hypoxia
risk increases
Acclimitization to altitude occurs over days to weeks and decreases the risk of High Altitude Illness
Sleep
and
Exercise
tolerance improve after acclimitization
Initial response to altitude is hypoxic
Ventilator
y response
Increased
Respiratory Rate
and
Minute Ventilation
Effect is tempered by carbon dioxide levels that fall, resulting in
Respiratory Alkalosis
Respiratory Alkalosis
results in decreased respiratory drive
Respiratory Alkalosis
is compensated over 48 hours by increased renal bicarbonate
Cardiovascular response (
Sympathetic Nervous System
)
Increased
Heart Rate
, venous tone and
Cardiac Output
Pulmonary Hypertension
(diffuse pulmonary vessel constriction) results from
Hypoxemia
response
Risk of
High Altitude Pulmonary Edema
(
HAPE
) in severe
Pulmonary Hypertension
Cerebral
Blood Flow
results from
Hypoxemia
response
Risk of
High Altitude Cerebral Edema
(
HACE
) in disordered autoregulation of cerebral
Hypertension
Erythropoietin
released from
Kidney
as a longer-term
Hypoxemia
response
Increases
Red Blood Cell
production and oxygen carrying capacity
Hypobaric
Hypoxemia
results in paradoxical and maladaptive physiologic changes at altitude (>1500 meters)
Hypoxic stress due to lower barometric pressure and less available oxygen (decreased PiO2 and FIOO2)
Symptom onset may begin within 6-12 hours of ascent
Fluid retention
Contrast with non-affected persons at altitude who experience diuresis
Other Changes at altitude that may exacerbate comorbid illness
Increased sympathetic tone
Pulmonary artery
Vasocon
striction
Increased
Systemic Vascular Resistance
Gas expands to take up a greater volume at altitude
Ambien
t air pressure (atmospheric pressure) decreases with increasing altitude
Allows trapped air (e.g.
Pneumothorax
) to expand
Example: helicopter transport with 5000 foot rise from sea level
Results in a pressure drop (14.7 psi to 12.7 psi)
Results in a
Gas Volume
increase of 15-20%
Boyles Law states P1*V1=P2*V2
Types
High Altitude Illness
Acute Mountain Sickness
High Altitude Cerebral Edema
(
HACE
)
High Altitude Pulmonary Edema
(
HAPE
)
Risk Factors
Rapid ascent (as opposed to gradual acclimatization)
Very high altitude
Significant physical exertion
Prior history of altitude sickness
Traveling from low altitude
Prolonged time at altitude
Obesity
Gene
tic susceptibility
Gene
tic factors affect a person's ability to acclimatize to altitude
Younger age
Aside from comorbidity, older adults may be less affected by altitude
Substances increasing High Altitude Illness risk (decrease hypoxic
Ventilator
y response)
Alcohol
use
Sleep
Aids
Symptoms
High Altitude Illness or HAI (Acute Mountain Sickness or AMS)
Common Symptoms
Headache
Malaise
Anorexia
Gene
ralized Weakness
Other Symptoms
Fatigue
Nausea
or
Vomiting
Insomnia
Irritable
Decreased
Urine Output
High Altitude Pulmonary Edema
(
HAPE
)
Dry cough
Congestion
Epistaxis
Dyspnea
or
Dyspnea
on Exertion
Chest
tightness
Tachycardia
Edema
Syncope
High Altitude Cerebral Edema
(
HACE
)
Altered Level of Consciousness
from confusion and
Hallucination
s to coma
Headache
Photophobia
Hypertension
Lassitude
Truncal
Ataxia
and inability to ambulate
Course
Onset: 6-12 hours following high altitude ascent
Diagnosis
Headache
and
One or more of the following
Fatigue
or weakness
Dizziness
or
Light Headedness
Gastrointestinal distress (
Nausea
,
Vomiting
,
Anorexia
)
Sleep
disturbance
Differential Diagnosis
Viral illness
Alcohol Hangover
Heat Exhaustion
Dehydration
Hypothermia
Hypoglycemia
Hyponatremia
Sedative Hypnotic
Medications
Carbon Monoxide Poisoning
(e.g. cooking in tent)
Migraine Headache
Complications (0.1 to 4 percent Incidence)
See Pathophysiology above
Altitudes above 11,400 feet (3500 meters) are associated with a more complicated course
High Altitude Pulmonary Edema
(
HAPE
)
High Altitude Cerebral Edema
(
HACE
)
Management
Very mild symptoms may resolve spontaneously with acclimitization
Immediate descent (at least 300 meters or 1000 feet) is most critical for moderate to severe symptoms
Descent of 500-1000 meters (1640 to 3280) is optimal (typically sufficient in all but the most severe cases)
Other measures for moderate to severe symptoms where descent is not immediately possible
Supplemental Oxygen
to keep
Oxygen Saturation
>90%
Acetazolamide
250 mg orally every 12 hours
Dexamethasone
8 mg PO/IV/IM loading dose, then 4 mg every 6 hours
Other measures to consider if descent is delayed and/or
Supplemental Oxygen
is unavailable
Nifedipine
ER 30 mg every 6 hours
Phosphodiesterase Inhibitor
s (
Tadalafil
)
Gamow Bag
(
Portable Hyperbaric Chamber
)
Symptomatic measures
Antiemetic
s (e.g.
Zofran
) for
Nausea
,
Vomiting
Acetaminophen
or
Ibuprofen
for
Headache
Prevention
Medication Prophylaxis
Indications
Travel to 11,000 feet in one day (or over 9,000 feet if history of prior altitude sickness)
Acetazolamide
(
Diamox
)
See
Acetazolamide
for mechanism
Adults: 125 mg every 12 hours (FDA approved)
Up to 250 mg twice daily may be used (but 125 mg is typically sufficient)
Children: 2.5 mg/kg up to 125 mg every 12 hours (off-label)
Start 1 day or more before ascent
Continue until acclimitization to the highest sleeping altitude (approximately 2 days)
Dexamethasone
Dose: 4 mg orally every 12 hours, or 2 mg every 6 hours (not FDA approved)
Alternative, in those who cannot take
Acetazolamide
Decreases inflammation, intracerebral pressure (ICP) and
Hypoxia
-related endothelial dysfunction
Some
Wilderness Medicine
experts recommend limiting
Dexamethasone
for treatment (not prophylaxis)
Risk of rebound mountain sickness when discontinued
May require taper with prolonged use (risk of adrenal suppression)
Does not speed acclimitization, but does reduce symptoms
Additional mild symptom management (severe symptoms require immediate descent)
Acetaminophen
Ibuprofen
600 mg every 8 hours
May have a prophylactic role (limited evidence)
Other agents that show promise in studies (but are experimental)
Nifedipine
ER 30 mg every 12 hours starting 24 hours before ascent
Tadalafil
Gene
ral Pointers
Gradual ascent to allow for acclimitization is the most important single preventive factor
Recognize the symptoms of Acute Mountain Sickness
Never ascend to sleep higher if you have symptoms
Descend if symptoms do not resolve or worsen
Never leave a person with altitude sickness alone
Maintain hydration
Avoid overexertion
Avoid
Alcohol
and
Sedative
s
For altitudes above 9800 feet (3000 meters)
Recommended ascent rate <1000 feet/day (300 meter/day)
Spend an additional rest day if ascent over 2000 feet (600 meters)
Do not sleep >2000 feet (600 meters) higher than the night before
Comorbid Conditions
See
Air Travel Restriction
Patients with asymptomatic cardiopulmonary disease may ascend safely to at least 8200 feet (2500 meters)
Conditions which absolutely contraindicate high altitude travel
Severe
Chronic Obstructive Pulmonary Disease
(
COPD
)
Uncontrolled
Congestive Heart Failure
(CHF)
Conditions for which caution should be
Exercise
d due to risk of exascerbation (emphasize acclimitization)
Arrhythmia
s
Coronary Artery Disease
Hypertension
Sickle Cell Anemia
(splenic infarct risk increases above 4900 feet (1500 meters)
Keep
Supplemental Oxygen
available
References
(2018) Presc Lett 25(2)
Candy and Contant in Herbert (2020) EM:Rap 20(3): 3-4
Comp and Rogich (2021) Crit Dec Emerg Med 35(4): 3-8
Comp and Rogich (2026) Crit Dec Emerg Med 40(9): 29-35
Basnyat (2003) Lancet 361(9373): 1967-74 [PubMed]
Fiore (2010) Am Fam Physician 82(9): 1103-10 [PubMed]
Hackett (2001) N Engl J Med 345(2): 107-14 [PubMed]
Type your search phrase here